Nedim Tokuyucu
İmparator
- 20 Ocak 2010
- 93.422
- 72.966
- 5.188
Sabah akşam korona konuşan manyaklar görüyorum
Koronavirüs Haberleri | Arşiv #1
- Konuyu Başlatan Mert Aslan
- Başlangıç tarihi
- Durum
Mustafa Özcelik
Tecrübeli Üye
- 14 Şubat 2009
- 6.147
- 4.169
- 2.418
Şu an Film contagion a bakıyom tam bu günleri anlatıyo
Nedim Tokuyucu
İmparator
- 20 Ocak 2010
- 93.422
- 72.966
- 5.188
Bepanthol kullan pişik önleyici iyi gelir
- 28 Ocak 2011
- 27.161
- 21.194
- 2.238
Cuma günü 6.30 civarı seyrediyordu şu an 6.41. Ödeme olduğu için bozacaktım zaten ama erken davrandık, sağlık olsun yapacak bir şey yok.
- 1 Mayıs 2018
- 57.364
- 48.148
- 3.873
Arif Ulu
Baba Gündüz
- 26 Kasım 2008
- 81.129
- 20.027
- 3.313
Herifler zamanı çok iyi kullandılar... Organize bir ülkeg. koreliler kaliteli maske yapiyorlarmis
20번 빨아 써도 멀쩡한 마스크 나온다
수십 번 빨아 쓸 수 있는 마스크 소재가 등장했다. 신종 코로나바이러스 감염증(코로나19)에 따른 마스크 품귀 현상을 줄일 수 있을지 주목된다. KAIST 신소재공학과 김일두 교수팀은 세탁 후에도 필터 효율이 유지되translate.google.com
- 28 Ocak 2011
- 27.161
- 21.194
- 2.238
Yunanistanın en çok kişi başına doktor düşen ülke olması ne alaka acaba onu çözemedim.
Demir Isik
Sarı Üye
- 5 Temmuz 2012
- 32.690
- 21.760
- 2.783
Nufusunun az olmasi buyuk avantaj ya
Bizim de tek avantajimiz genc nufus oranimizin fazla olmasi ama yine de avrupanin en kalabalik 2. ulkesi olup en dusuk yatak oranina sahip ulkelerden biri oldugumuz gercegini degistirmiyor
Mustafa Özcelik
Tecrübeli Üye
- 14 Şubat 2009
- 6.147
- 4.169
- 2.418
Yok ben Zombie leri sonrada uzalıları bekliyom bir kac sorum var kendilerine
Arif Ulu
Baba Gündüz
- 26 Kasım 2008
- 81.129
- 20.027
- 3.313
H.o.
- 1 Mayıs 2018
- 57.364
- 48.148
- 3.873
Conclusion
Chloroquine can both both prevent and treat malaria. Chloroquine can prevent and treat coronavirus in primate cells (Figure 1 and Figure 2). According to South Korean and China human treatment guidelines, chloroquine is effective in treating COVID-19. Given chloroquine’s human safety profile and existence, it can be implemented today in the U.S., Europe and the rest of the world. Medical doctors may be reluctant to prescribe chloroquine to treat COVID-19 since it is not FDA approved for this use. The United States of America and other countries should immediately authorize and indemnify medical doctors for prescribing chloroquine to treat COVID-19. We must explore whether chloroquine can safely serve as a preventative measure prior to infection of COVID-19 to stop further spread of this highly contagious virus.
Chloroquine can both both prevent and treat malaria. Chloroquine can prevent and treat coronavirus in primate cells (Figure 1 and Figure 2). According to South Korean and China human treatment guidelines, chloroquine is effective in treating COVID-19. Given chloroquine’s human safety profile and existence, it can be implemented today in the U.S., Europe and the rest of the world. Medical doctors may be reluctant to prescribe chloroquine to treat COVID-19 since it is not FDA approved for this use. The United States of America and other countries should immediately authorize and indemnify medical doctors for prescribing chloroquine to treat COVID-19. We must explore whether chloroquine can safely serve as a preventative measure prior to infection of COVID-19 to stop further spread of this highly contagious virus.
- 26 Kasım 2012
- 185.570
- 258.144
- 5.998
bakanin verdigi link ilginc
bu ilaclari alip bulundurmali
acaba trdeki muadilleri nedir
The UK government has banned the parallel export and “hoarding” of three drugs being used to treat coronavirus patients in China in anticipation of shortages in Britain following the Covid-19 pandemic.
The export of the US-based AbbVie’s Kaletra / Aluvia, a combination lopinavir and ritonavir, the generic drug chloroquine phosphate and the generic drug hydroxychloroquine is being restricted to meet the needs of UK patients, the government said.
Hydroxychloroquine was placed on the restricted list from 14 March and Kaletra and chloroquine phosphate were added on 26 February.
The three drugs are marketed for other indications but are being administered to Covid-19 patients in clinical trials in China. For a list of Covid-19 clinical trials, search the GlobalData Pharma Intelligence Center Clinical Trials database.
Kaletra is a small-molecule, fixed-dose combination antiviral drug marketed in the EU, US and other regions in combination with other antiretroviral agents for human immunodeficiency virus (HIV). It is under investigation in 16 ongoing or planned clinical trials for Covid-19 in China, according to the GlobalData Clinical Trials database. Kaletra is formulated as capsules, tablets, coated tablets, film-coated tablets and solution for oral route of administration.
Chloroquine phosphate is a generic antimalarial drug derived from quinolone, marketed in the UK by Alinter Ltd in Essex, Crescent Pharma Ltd in Hampshire and The Boots Company in Nottingham and by other companies in multiple other regions. It is in 10 trials for Covid-19 in China, including one in combination with Kaletra, as chloroquine phosphate is believed to have broad-spectrum antiviral activities, although it is not approved as an antiviral agent. It is formulated as a syrup for oral administration. Recipharm, based in Stockholm, Sweden, manufactures the drug under the brand name Klorokinfosfat RPH Pharma for marketing in Sweden by Astimex Pharma. In March, the chief medical officer (CMO) noted increased demand and said it is securing a supply of the product in case of demand suddenly rose.
Hydroxychloroquine is an aminoquinoline derivative which acts as an anti-infective and antirheumatic agent. It is marketed for rheumatoid arthritis, discoid and systemic lupus erythematosus and juvenile idiopathic arthritis and is manufactured as film-coated tablets for oral administration.
bu ilaclari alip bulundurmali
acaba trdeki muadilleri nedir
The UK government has banned the parallel export and “hoarding” of three drugs being used to treat coronavirus patients in China in anticipation of shortages in Britain following the Covid-19 pandemic.
The export of the US-based AbbVie’s Kaletra / Aluvia, a combination lopinavir and ritonavir, the generic drug chloroquine phosphate and the generic drug hydroxychloroquine is being restricted to meet the needs of UK patients, the government said.
Hydroxychloroquine was placed on the restricted list from 14 March and Kaletra and chloroquine phosphate were added on 26 February.
The three drugs are marketed for other indications but are being administered to Covid-19 patients in clinical trials in China. For a list of Covid-19 clinical trials, search the GlobalData Pharma Intelligence Center Clinical Trials database.
Kaletra is a small-molecule, fixed-dose combination antiviral drug marketed in the EU, US and other regions in combination with other antiretroviral agents for human immunodeficiency virus (HIV). It is under investigation in 16 ongoing or planned clinical trials for Covid-19 in China, according to the GlobalData Clinical Trials database. Kaletra is formulated as capsules, tablets, coated tablets, film-coated tablets and solution for oral route of administration.
Chloroquine phosphate is a generic antimalarial drug derived from quinolone, marketed in the UK by Alinter Ltd in Essex, Crescent Pharma Ltd in Hampshire and The Boots Company in Nottingham and by other companies in multiple other regions. It is in 10 trials for Covid-19 in China, including one in combination with Kaletra, as chloroquine phosphate is believed to have broad-spectrum antiviral activities, although it is not approved as an antiviral agent. It is formulated as a syrup for oral administration. Recipharm, based in Stockholm, Sweden, manufactures the drug under the brand name Klorokinfosfat RPH Pharma for marketing in Sweden by Astimex Pharma. In March, the chief medical officer (CMO) noted increased demand and said it is securing a supply of the product in case of demand suddenly rose.
Hydroxychloroquine is an aminoquinoline derivative which acts as an anti-infective and antirheumatic agent. It is marketed for rheumatoid arthritis, discoid and systemic lupus erythematosus and juvenile idiopathic arthritis and is manufactured as film-coated tablets for oral administration.
Ismail ARI
Büyük Kaptan
- 3 Aralık 2008
- 29.531
- 12.540
- 2.868
Ismail ARI
Büyük Kaptan
- 3 Aralık 2008
- 29.531
- 12.540
- 2.868
Tugay Elser
Büyük Kaptan
- 4 Ağustos 2017
- 27.110
- 15.000
- 1.878
Trumpin asiyi satin almadi istedigi Tübingenli firmanin 80% Dietmar Hopp'unmus.
O da asiyi bulursak asi tek bölgesel kisilere degil, tüm insanlar icin olacak demis.
m.manager-magazin.de
O da asiyi bulursak asi tek bölgesel kisilere degil, tüm insanlar icin olacak demis.
Dietmar Hopp lässt Donald Trump bei Curevac abblitzen
Der deutsche Milliardär Dietmar Hopp hat den Vorstoß von US-Präsident Donald Trump abgewehrt, einen möglichen Impfstoff der deutschen Firma CureVac hauptsächlich für die USA zu sichern. Hopp ist Haupteigner der Tübinger Firma. In seiner Ablehnung am Sonntagabend…
m.manager-magazin.de
- 1 Mayıs 2018
- 57.364
- 48.148
- 3.873
Common side effects include muscle problems, loss of appetite, diarrhea, and skin rash.[1] Serious side effects include problems with vision, muscle damage, seizures, and low blood cell levels.[1] It appears to be safe for use during pregnancy.[1][2] Chloroquine is a member of the drug class 4-aminoquinoline.[1] It works against the asexual form of malaria inside the red blood cell.[1]
- 1 Mayıs 2018
- 57.364
- 48.148
- 3.873
Trumpin asiyi satin almadi istedigi Tübingenli firmanin 80% Dietmar Hopp'unmus.
O da asiyi bulursak asi tek bölgesel kisilere degil, tüm insanlar icin olacak demis.
Dietmar Hopp lässt Donald Trump bei Curevac abblitzen
Der deutsche Milliardär Dietmar Hopp hat den Vorstoß von US-Präsident Donald Trump abgewehrt, einen möglichen Impfstoff der deutschen Firma CureVac hauptsächlich für die USA zu sichern. Hopp ist Haupteigner der Tübinger Firma. In seiner Ablehnung am Sonntagabend…
way serro trump way, sirketi alip kendine kahraman ilan edecekti
Arif Ulu
Baba Gündüz
- 26 Kasım 2008
- 81.129
- 20.027
- 3.313
İşte Alman Vizyonu !!!!!!Trumpin asiyi satin almadi istedigi Tübingenli firmanin 80% Dietmar Hopp'unmus.
O da asiyi bulursak asi tek bölgesel kisilere degil, tüm insanlar icin olacak demis.
Dietmar Hopp lässt Donald Trump bei Curevac abblitzen
Der deutsche Milliardär Dietmar Hopp hat den Vorstoß von US-Präsident Donald Trump abgewehrt, einen möglichen Impfstoff der deutschen Firma CureVac hauptsächlich für die USA zu sichern. Hopp ist Haupteigner der Tübinger Firma. In seiner Ablehnung am Sonntagabend…
Deutschland Deutschland Über Alles
Über Alles in der Welt
- 19 Kasım 2010
- 8.824
- 3.798
- 1.438
Yangının çıkış nedeni araştırılacak.
Ona göre ödeme yapılacak.
6 aya kadar sürebilir.
Müşteri kaybı inanılmaz bu işlerde.
6 aylık/1 senelik zorunlu kontratlar mevcut. Kimse seni 6 ay beklemez başka şirketlerle anlaşır.
Şu an sadece tırlar ve soğutma sistemlerini yeniden almaya kalksan 10 milyon euro gider.
17 tane tır yandı.
Soğutma odaların maliyeti çok büyük.
Bu iş buraya kadarmış.
Bu şirketten 47 aile geçiniyor.
1 ay paralar geçikse insanlar derde giriyor.
Neyse ben çıkıyorum.
Daha çok işim var.
Gscimbom mobil
Gökhan Gel
Ulubatlı Souness
- 22 Şubat 2017
- 31.902
- 28.133
- 1.933
İlgisini çeken varsa okusun derli toplu sade bir yazı güzel grafikler var.
Hangi ülkede kişi başına kaç doktor ve hastane yatağı düşüyor?
Hükümetler, koronavirüs salgınının daha da yayılmasının önüne geçmeye çalışırken sağlık kurumları da virüs bulaşan kişilerin tedavisine yoğunlaşmış durumda. Peki, dünyada hangi ülkede kişi başına kaç hastane yatağı düşüyor?tr.euronews.com
Tabii esas sıkıntı yatak kapasitesinden ziyade solunum cihazı. Allah düşmanıma vermesin de akciğerleri bitiren rahatsızlık geldikten sonra pamuk yatakta yatsan ne olur, çivili kanepede yatsan ne.
- Durum